I've heard before that the company is doing all th
Post# of 15624
(Total Views: 411)
Posted On: 08/23/2018 3:35:51 PM
Re: LeaveMeAlone #13634
I've heard before that the company is doing all their trials in Israel, so they feel that showing the trial on our clinical trials database is unnecessary. The problem as I see it is the Israeli's apparently don't have a similar site where trials are posted.
I think it's much more about playing their cards close to the vest. If they were in clinical trials, the entire trial protocol would be revealed, while investors would be much better informed, so would other companies looking to compete with them. I frankly believe most of the competition knows precisely what they're doing as they have people they can speak with where it's being done, but I can't prove that.
I believe that we'd be far better informed if trials were in the clinical trials database, and updated routinely, The one trial they originally put there was the Phase 1 for the psoriasis cream, but it was never updated on either schedule, or to show it was being done in two parts. When the company spoke of completing the Phase 1, all believed it was finished, not that it would be followed by what I guess would be referred to as a Phase 1B.
If the company openly answered questions about upcoming trials, I think our price would be substantially higher, if we liked the answers. For instance, I'd be happy to learn that the fibromyalgia trial is being done with people who have the disease, but I'd be unhappy to find that it isn't. Likewise the other trials being planned. I know Phase 1 isn't intended to determine efficacy, it's about safety, but efficacy is often demonstrated in Phase 1 and in some cases no matter how safe a Phase 1 is, if no efficacy is seen when the drug is used with patients with the disease it's intended for, the drug goes no further.
I have no idea who wouldn't permit the cream to be tried on patients with psoriasis, it may have been out of the company's hands, but I certainly would have fought to try it with otherwise healthy people, but people that have the disease. I've known at least a few of them. I think the same is true of people with autism, PTSD, etc., trial candidates can be found for Phase 1 Trials where both safety and efficacy can be determined. I believe if the trials were done here in the U.S. the trial would be permitted in that way, but I cannot speak to what's permitted in Israel, except to say that they seem more open to medical experimentation, not less, they certainly have been more open to the use of cannabis in medicine.
Gary
I think it's much more about playing their cards close to the vest. If they were in clinical trials, the entire trial protocol would be revealed, while investors would be much better informed, so would other companies looking to compete with them. I frankly believe most of the competition knows precisely what they're doing as they have people they can speak with where it's being done, but I can't prove that.
I believe that we'd be far better informed if trials were in the clinical trials database, and updated routinely, The one trial they originally put there was the Phase 1 for the psoriasis cream, but it was never updated on either schedule, or to show it was being done in two parts. When the company spoke of completing the Phase 1, all believed it was finished, not that it would be followed by what I guess would be referred to as a Phase 1B.
If the company openly answered questions about upcoming trials, I think our price would be substantially higher, if we liked the answers. For instance, I'd be happy to learn that the fibromyalgia trial is being done with people who have the disease, but I'd be unhappy to find that it isn't. Likewise the other trials being planned. I know Phase 1 isn't intended to determine efficacy, it's about safety, but efficacy is often demonstrated in Phase 1 and in some cases no matter how safe a Phase 1 is, if no efficacy is seen when the drug is used with patients with the disease it's intended for, the drug goes no further.
I have no idea who wouldn't permit the cream to be tried on patients with psoriasis, it may have been out of the company's hands, but I certainly would have fought to try it with otherwise healthy people, but people that have the disease. I've known at least a few of them. I think the same is true of people with autism, PTSD, etc., trial candidates can be found for Phase 1 Trials where both safety and efficacy can be determined. I believe if the trials were done here in the U.S. the trial would be permitted in that way, but I cannot speak to what's permitted in Israel, except to say that they seem more open to medical experimentation, not less, they certainly have been more open to the use of cannabis in medicine.
Gary
(0)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼